Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 05, 2016 8:04 PM ET

Healthcare Equipment and Supplies

Company Overview of PowerVision, Inc.

Company Overview

PowerVision, Inc. develops fluid-controlled intraocular lens. It offers FluidVision accommodating intraocular lens technology, which restores the vision of youth to middle aged or elderly individuals affected by presbyopia and/or cataracts. The company was incorporated in 2002 and is based in Belmont, California.

260 Harbor Boulevard

Belmont, CA 94002

United States

Founded in 2002





Key Executives for PowerVision, Inc.

Co-Founder, Chief Executive Officer, President and Director
Age: 54
Founder, Chief Business Officer and Director
Senior Vice President of Regulatory/Quality/Clinical and General Counsel
Age: 54
Vice President of Materials and Technology
Vice President of R&D
Age: 51
Compensation as of Fiscal Year 2015.

PowerVision, Inc. Key Developments

PowerVision Appoints Douglas D. Koch to its Scientific Advisory Board

PowerVision, Inc. announced that Douglas D. Koch, M.D., the Allen, Mosbacher, and Law Chair of Ophthalmology, and Professor of Ophthalmology, at Baylor College of Medicine has joined the company's Scientific Advisory Board. Koch will join the distinguished group who will guide PowerVision's team in the development of the FluidVision(TM) lens, the first fluid based accommodating intraocular lens designed to permanently restore clear vision at all distances for patients with cataracts and presbyopia, as the company works to secure its European approval, launch its pivotal study in the U.S. and prepare for a U.S. launch. The panel provides guidance on all aspects of product development, including surgical technique, design of the delivery system, clinical trial design and market positioning.

PowerVision, Inc. Announces Key Six Month Data from Fluidvision Pilot Study

PowerVision, Inc. announced that six-month data from the pilot study of the FluidVision lens confirmed the lens' ability to restore vision at all distances. Results were presented by principal investigator Professor Paul Roux of the Optimed Eye and Laser Clinic in Pretoria, South Africa at the American Society of Cataract and Refractive Surgery Annual Symposium, which concludes here immediately. The FluidVision lens provides True Accommodation by mimicking the eye's natural accommodative process to change shape and adjust focus the way that young, healthy eyes do. The lens is implanted using the same surgical techniques as are used with traditional intraocular lenses. The pilot study included 20 patients who were candidates for cataract surgery and underwent implantation of the FluidVision lens in one eye. Initial results showed excellent distance vision, averaging better than 20/20 at six-month follow-up. Visual acuities at intermediate and near were also impressive at six months, approximately 20/25 and 20/33 respectively, when tested in one eye, and allowed patients to read without glasses. The visual outcomes provided by the lens should improve even more in patients when they have lenses implanted in both eyes. The study also confirmed the safety of the lens, with no clinical complications or adverse events reported. Separate studies presented at the symposium highlighted the FluidVision lens' unique delivery system, PowerJect, which allows physicians to easily prepare the lens for implantation and then implant it, and also demonstrated that the lens capsule is remarkably stable over time after implantation of the lens.

PowerVision, Inc. Announces First Patients in Multi-Center Study Implanted with FluidVision Accommodating Intraocular Lens

PowerVision, Inc. announced that the first 10 patients have received lens implants in its multi-center clinical study assessing the performance of the lens in cataract patients. These patients received their implants at the three eye centers in South Africa that are participating in the study; four sites in Germany are also participating in the study and will begin enrolling patients later in 2014. The planned enrollment in this study is 115 participants undergoing cataract surgery. This study will form the basis for PowerVision's CE marking of the FluidVision lens in the European Union, which is expected to occur sometime next year. Accommodation refers to the eye's ability to dynamically adjust focus to see up close and at a distance. The FluidVision lens, PowerVision's novel fluid-controlled accommodating intraocular lens, contains fluid inside the lens that moves in response to the natural muscle forces in the eye. The FluidVision lens provides True Accommodation(TM) by mimicking the eye's natural accommodative process, becoming thicker when the patient needs to see up close or thinner when he or she needs to see far away.

Similar Private Companies By Industry

Company Name Region
Stanley InnerSpace United States
Connect America LLC United States
Z & D Medical Services, Inc. United States
Expeditor Systems, Inc. United States
HotSpur Technologies, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact PowerVision, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at